logo
Plus   Neg
Share
Email

Clover Biopharma Begins Phase 1 Trial For COVID-19 Vaccine - Quick Facts

Clover Biopharmaceuticals said first participants have been dosed in the Phase 1 first-in-human study evaluating the company's COVID-19 vaccine candidate, SCB-2019. The study is being conducted at Linear Clinical Research in Perth, Australia and will enroll approximately 90 healthy adult participants and 60 healthy elderly participants.

The study will evaluate two adjuvant systems - GSK's (GSK.L,GSK) pandemic adjuvant system as well as Dynavax's (DVAX) CpG 1018 adjuvant combined with alum. An adjuvant is added to some vaccines to enhance the immune response. Clover has expanded its collaborations with GSK and Dynavax to include clinical supply of the adjuvants.

Clover Biopharma expects preliminary safety and immunogenicity results for the Phase 1 study in August 2020. The planning for a global Phase 2b/3 vaccine efficacy trial has begun, with initiation targeted by year-end 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Biotechnology company Seattle Genetics, Inc. (SGEN) and Japanese pharmaceutical company Astellas Pharma Inc. (ALPMY, ALPMY) announced Friday that a phase 3 trial of PADCEV (enfortumab vedotin-ejfv) met its primary endpoint of overall survival compared to chemotherapy. The results were reviewed by... MWE Investments is recalling dual fuel portable generators citing fire risk, according to the U.S. Consumer Product Safety Commission. The recall involves about 7,500 units of Westinghouse WGen5300DFv Dual Fuel Portable Generators and Westinghouse iGen4500DF Dual Fuel Inverter Portable Generators. According to the agency, the dual fuel portable generators can leak fuel. Apple Inc. (AAPL) will launch an online store in India on September 23, offering the tech giant's full range of products and support directly to customers across the country for the first time.
Follow RTT